Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of a Strategy of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Chemosensitive Relapsed Follicular Lymphoma
Conditions
Interventions
Reduced_intensity conditioning
Locations
26
France
University Hospital Angers
Angers, Angers, France
Service Hématologie, Hôpital Minjoz
Besançon, France
Service Hématologie, Hôpital Augustin Morvan
Brest, France
University Hospital, Caen
Caen, France
Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand
Clermont-Ferrand, France
CHU Grenoble
Grenoble, France
Start Date
February 3, 2011
Primary Completion Date
September 28, 2017
Completion Date
September 28, 2017
Last Updated
August 9, 2018
NCT05436418
NCT07101588
NCT06093867
NCT04146870
NCT06785818
NCT07244419
Lead Sponsor
University Hospital, Bordeaux
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions